Preoperative Prdx1 (ng/mL) was significantly higher in NAFLD patients with obesity than in normal controls (25.51 [18.51-32.83] vs. 12.38 [8.370-15.71], p<0.001). Here, PRDX1 is linked to metabolic dysfunction-associated steatotic liver disease.